Skip to main content
Top
Metadata
Title
The self peptide annexin II (208–223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells
Authors
Susanne Heinzel
Delphine Rea
Rienk Offringa
Graham Pawelec
Publication date
01-02-2001
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 12/2001
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620000163

Other articles of this Issue 12/2001

Cancer Immunology, Immunotherapy 12/2001 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine